NAMPT and type 2 diabetes mellitus: Finally, expression changes of the candidate genes were validated in peripheral blood from a separate clinical cohort (15 T2DM patients, 20 controls) using qRT-PCR.<h4>Results</h4>Four core genes (PNLIP, BUB1, CTSB, NAMPT) were identified as candidate signature genes.